Trial One | Trial Two | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
No information | In-person discussion | p-value | In-person discussion | Video | p-value | |||||
n = 38 | n = 31 | n = 59 | n = 55 | |||||||
Subject Area | μ (σ) | Median (range) | μ (σ) | Median (range) | p≤ | μ (σ) | Median (range) | μ (σ) | Median (range) | p≤ |
HIV/AIDS Definition | 2.66 (1.15) | 3 (0–4) | 3.48 (0.68) | 4 (1–4) | 0.00 | 3.51 (0.68) | 4 (1–4) | 3.33 (0.86) | 4 (1–4) | 0.35 |
HIV Transmission | 2.82 (1.18) | 3 (1–5) | 3.90 (0.94) | 4 (2–5) | 0.00 | 4.02 (0.96) | 4 (2–5) | 4.22 (0.79) | 4 (2–5) | 0.34 |
HIV Prevention | 2.84 (1.37) | 3 (0–5) | 3.52 (1.03) | 4 (2–5) | 0.04 | 3.73 (1.19) | 4 (1–5) | 3.73 (1.10) | 4 (1–5) | 0.85 |
HIV Testing | 2.84 (1.42) | 3 (0–6) | 3.65 (1.20) | 4 (1–5) | 0.01 | 3.73 (1.27) | 4 (0–6) | 4.18 (1.06) | 4 (2–6) | 0.05 |
Rapid HIV Testing | 2.03 (1.38) | 2 (0–5) | 4.26 (1.12) | 4 (2–6) | 0.00 | 4.29 (1.25) | 4 (2–6) | 4.45 (1.14) | 5 (1–6) | 0.39 |
All Subject Areas | 13.34 (4.45) | 13 (6–24) | 18.71 (3.50) | 20 (10–24) | 0.00 | 19.2 (3.63) | 20 (11–25) | 20.0 (2.98) | 21 (11–25) | 0.33 |